Location of Repository

Current perspectives concerning the multimodal therapy in Glioblastoma

By Grigore Florina, Brehar Felix Mircea and Gorgan Mircea Radu

Abstract

GBM (Glioblastoma) is the most common, malignant type of primary brain tumor. It has a dismal prognosis, with an average life expectancy of less than 15 months. A better understanding of the tumor biology of GBM has been achieved in the past decade and set up new directions in the multimodal therapy by targeting the molecular paths involved in tumor initiation and progression. Invasion is a hallmark of GBM, and targeting the complex invasive mechanism of the tumor is mandatory in order to achieve a satisfactory result in GBM therapy. The goal of this review is to describe the tumor biology and key features of GBM and to provide an up-to-date overview of the current identified molecular alterations involved both in tumorigenesis and tumor progression

Topics: glioblastoma, molecular pathways, invasion, targeted therapy, Neurology. Diseases of the nervous system, RC346-429
Publisher: De Gruyter Open
Year: 2015
DOI identifier: 10.1515/romneu-2015-0001
OAI identifier: oai:doaj.org/article:80652067751046d1907f2ef3bb2ac042
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/2344-4959 (external link)
  • https://doaj.org/toc/1220-8841 (external link)
  • http://www.degruyter.com/view/... (external link)
  • https://doaj.org/article/80652... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.